Trial Profile
Brain Myelination Effects of Paliperidone Palmitate vs. Oral Risperidone in First Episode Schizophrenia.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2012
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Biomarker; Pharmacodynamics
- 15 Jun 2012 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 15 Jun 2012 Planned initiation date changed from 1 Oct 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 26 Oct 2011 New trial record